BB Biotech AG (XSWX:BION) Future 3-5Y EPS without NRI Growth Rate: -64.32 (As of Sep. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BION BB Biotech AG XSWX:BION
27 GF Score
Price CHF52.50
! 3 Warning Signs
View Full Analysis

What is BB Biotech AG Future 3-5Y EPS without NRI Growth Rate?

BB Biotech AG XSWX:BION -0.57% 27 Future 3-5Y EPS without NRI Growth Rate is -64.32 as of Sep. 14, 2026. GuruFocus rates XSWX:BION with a GF Score™ of 27/100. The stock has 3 warning signs investors should review. Among 413 Biotechnology companies, BB Biotech AG ranks worse than 97.82% on this metric.

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, BB Biotech AG's Future 3-5Y EPS without NRI Growth Rate is -64.32.

BB Biotech AG  (XSWX:BION) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

BB Biotech AG Future 3-5Y EPS without NRI Growth Rate Related Terms

XSWX:BION vs VRTX, REGN, MRNA: Future 3-5Y EPS without NRI Growth Rate Comparison

For the Biotechnology subindustry, BB Biotech AG's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG Future 3-5Y EPS without NRI Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Future 3-5Y EPS without NRI Growth Rate falls into.


XSWX:BION
27GF Score
BB Biotech AG XSWX:BION
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Future 3-5Y EPS without NRI Growth Rate of -64.32 mean?
BB Biotech AG (XSWX:BION) has a Future 3-5Y EPS without NRI Growth Rate of -64.32 as of Sep. 14, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #404 out of 413 companies in the Biotechnology industry, placing it in the top 97.8%.
Is BB Biotech AG's Future 3-5Y EPS without NRI Growth Rate too high?
BB Biotech AG's current Future 3-5Y EPS without NRI Growth Rate is -64.32. Based on the distribution chart, BB Biotech AG ranks #404 out of 413 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BB Biotech AG has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Future 3-5Y EPS without NRI Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #404 out of 413 companies for Future 3-5Y EPS without NRI Growth Rate. This places BB Biotech AG in the lower half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 21.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Biotechnology company?
The median Future 3-5Y EPS without NRI Growth Rate among Biotechnology companies is 21.97, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for BB Biotech AG and its competitors. For the Biotechnology industry, the median Future 3-5Y EPS without NRI Growth Rate is 21.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BB Biotech AG's current Future 3-5Y EPS without NRI Growth Rate is -64.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Future 3-5Y EPS without NRI Growth Rate of -64.32. The current Future 3-5Y EPS without NRI Growth Rate is -64.32. BB Biotech AG's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Future 3-5Y EPS without NRI Growth Rate is -64.32 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
27GF Score

Get the complete analysis for XSWX:BION

Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF52.50
Price